Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia

Ayami Yoshimi, Irith Baumann, Monika Führer, Eva Bergsträsser, Ulrich Göbel, Karl Walter Sykora, Thomas Klingebiel, Ute Gross-Wieltsch, Marry M. Van Den Heuvel-Eibrink, Alexandra Fischer, Peter Nöllke, Charlotte Niemeyer

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

37 Citaten (Scopus)

Samenvatting

It is currently unknown whether immunosuppressive therapy or hematopoietic stem cell transplantation is the most appropriate treatment strategy for children with refractory cytopenia and normal karyotype or trisomy 8. We report on 31 children with hypoplastic refractory cytopenia treated with immunosuppressive therapy consisting of antithymocyte globulin and cyclosporine. At 6 months, 22 of 29 evaluable patients had a complete or partial response; a total of ten patients achieved a complete response at varying time points. Six patients subsequently received a transplant because of non-response, progression to advanced myelodysplastic syndrome or evolution of monosomy 7. Overall and failure-free survival rates at 3 years were 88% and 57%, respectively.

Originele taal-2Engels
Pagina's (van-tot)397-400
Aantal pagina's4
TijdschriftHaematologica
Volume92
Nummer van het tijdschrift3
DOI's
StatusGepubliceerd - mrt. 2007
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia'. Samen vormen ze een unieke vingerafdruk.

Citeer dit